Company / Net Debt per Share
Protagonist Therapeutics, Inc. Net Debt per Share History
FY2019-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.90
FY2019
5-year range
-
FY2019-FY2019
Trend
-
vs FY2018
Sector context
#61 of 82
Health Care
What the data says
At $-0.90, Protagonist Therapeutics, Inc.'s net debt per share ranks #22 of 82 in the Health Care sector.
Based on SEC 10-K filings.
-0.90 in FY2019.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#22 of 82 in Health CareTop 26% of 82This company -$0.90 Sector average $13.70
▼
-106.5% below sector average
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -$0.90 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Feb 28, 2026